Novo Nordisk and Eli Lilly Just Got Some Fantastic News
Novo Nordisk and Eli Lilly receive positive news amid ongoing developments in drug discovery and aging research.
15 trends tracked about this subject — the full history, oldest to newest below.
Novo Nordisk and Eli Lilly receive positive news amid ongoing developments in drug discovery and aging research.
A biotech startup run by thousands of AI agents discovers a promising lung-cancer drug, sparking global attention.
Scientific coverage highlights virtual cells built from 4D AI models and digital twins accelerating drug discovery.
Coverage explores how a team of artificial intelligence models successfully discovered a promising new drug for lung cancer.
An artificial intelligence-designed drug makes patients' blood look biologically younger, according to a new study.
Recent coverage explores potential links between a lung disease drug and the slowing of biological aging.
A clinical trial has indicated that a drug developed through artificial intelligence may have the capacity to make patients biologically younger.
A new study suggests that a drug developed through artificial intelligence may have the potential to slow the biological process of aging.
Researchers have discovered that a compound found in magic mushrooms may block severe chemotherapy-induced pain in mice.
Researchers have discovered that an old small molecule drug may enable the burning of fat while preserving lean muscle in obese mice.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Science story right now — PULSE is tracking how fast it spreads.
Bristol Myers Squibb is partnering with Nvidia to construct what it claims will be the most powerful AI supercomputer in the pharmaceutical industry.
An experimental therapy already proven safe in humans reduces multiple signs of Alzheimer's disease in mice.
Anthropic has entered the drug discovery sector with the launch of a dedicated AI research workbench and the development of internal pre-clinical trials.